The Summary
Researchers analyzed data from 366 Finnish children to see if high-dose vitamin D3 (1,200 IU daily) during their first two years reduced autism spectrum (ASD) traits at ages 6 to 8, compared to a standard dose (400 IU). Using parent-reported screening questionnaires, the study found no overall difference between the supplementation groups. However, blood tests revealed that boys with higher actual vitamin D levels at ages one and two had significantly fewer ASD-related traits, suggesting a complex, sex-specific link between biological vitamin D levels and neurodevelopment.
Why this is interesting
While standard high-dose supplementation did not show a blanket benefit, the study reveals an intriguing twist: boys with higher actual blood levels of vitamin D had fewer autism-related traits. This suggests that how a child's body processes vitamin D might matter more than the raw dose they swallow. For parents, it underscores that while standard vitamin D is crucial for early development, mega-dosing infants won't automatically alter neurodevelopmental outcomes. It highlights the need for personalized approaches and further research into how gender influences vitamin D's impact on the brain.